Infectious Diseases Market Research Reports & Industry Analysis
Infectious Diseases Industry Research & Market Reports
-
Infectious Disease Therapeutics Market Assessment, By Mode of Treatment [Vaccines, Drugs], By Infection Type [Viral Infection, Bacterial Infection, Fungal Infection, Parasitic Infection, Others], By Route of Administration [Oral, Parenteral, Others], By Diagnostic Technique [Immunodiagnostics, Polymerase Chain Reaction, Clinical Microbiology, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing, Next Generation Sequencing, DNA Microarray, Others], By End-user [Hospitals, Diagnostic Centres, Retail Pharmacy, Others], By Region, Opportunities and Forecast, 2017-2031F
... Chain Reaction, Clinical Microbiology, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing, Next Generation Sequencing, DNA Microarray, Others], By End-user [Hospitals, Diagnostic Centres, Retail Pharmacy, Others], By Region, Opportunities and Forecast, 2017-2031F Global infectious disease therapeutics ... Read More
-
2024 Israel Infectious Disease Testing Market Shares-Competitive Analysis of Leading and Emerging Market Players
... and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. The companies profiled in the report include: Abbott Agilent Technologies Applied Gene Technologies Arca Biopharma ... Read More
-
2024 Panama Infectious Disease Testing Market Shares-Competitive Analysis of Leading and Emerging Market Players
... and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. The companies profiled in the report include: Abbott Agilent Technologies Applied Gene Technologies Arca Biopharma ... Read More
-
2024 Myanmar Infectious Disease Testing Market Shares-Competitive Analysis of Leading and Emerging Market Players
... and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. The companies profiled in the report include: Abbott Agilent Technologies Applied Gene Technologies Arca Biopharma ... Read More
-
Immunodiagnostics Market Assessment, By Type [Radioimmunoassay, ELISA, Chemiluminescent immunoassay, Fluorescent immunoassay, Lateral flow assay, Rapid Test, Others], By Product [Reagents, Instruments, Software & Services], By Application [Oncology, Endocrinology, Infectious diseases, Allergy, Autoimmune Diseases, Environmental Pollution, Food Technology, Proteomics, Cardiac Biomarker, Drug Monitoring, Others], By End-user [Hospitals, Clinical Laboratories, Academics & Research Centers, Pharma & Biotech Industry, Others], By Region, Opportunities and Forecast, 2017-2031F
... Food Technology, Proteomics, Cardiac Biomarker, Drug Monitoring, Others], By End-user [Hospitals, Clinical Laboratories, Academics & Research Centers, Pharma & Biotech Industry, Others], By Region, Opportunities and Forecast, 2017-2031F Global immunodiagnostics market size was valued at ... Read More
-
Biopharmaceuticals Contract Manufacturing Market Size, Trends, Analysis, and Outlook By Source (Mammalian, Non-mammalian), By Service (Process Development, Fill & Finish Operations, Analytical & QC studies, Packaging), By Product (Biologics, BiosimilarsOthers), By Therapeutic Area (Oncology, Autoimmune Diseases, Metabolic Diseases, Cardiovascular Diseases, Neurology, Infectious Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030
... Diseases, Metabolic Diseases, Cardiovascular Diseases, Neurology, Infectious Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Biopharmaceuticals Contract Manufacturing market size is poised to register 5.82% growth from 2024 to 2030, presenting significant ... Read More
-
Viral Vector Production Market Size, Trends, Analysis, and Outlook By Indication (Cancer, Genetic Disorders, Infectious Diseases, Other Diseases), By Application (Gene Therapy, Vaccinology), By Viral Vector (Adenoviral Vectors, Lentiviral Vectors, Retroviral Vectors, Adeno-Associated Viral Vectors, Others), by Region, Country, Segment, and Companies, 2024-2030
... Others), by Region, Country, Segment, and Companies, 2024-2030 The global Viral Vector Production market size is poised to register 17.68% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. ... Read More
-
Cell and Gene Therapy Bioanalytical Testing Services Market Size, Trends, Analysis, and Outlook By Test Type (Bioavailability & Bioequivalence Studies, Pharmacokinetics, Pharmacodynamics, Others), By Product (Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy), By Stage Of Development (Non-Clinical, Clinical), By Indication (Oncology, Infectious Diseases, Neurological disorders, Rare Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030
... Development (Non-Clinical, Clinical), By Indication (Oncology, Infectious Diseases, Neurological disorders, Rare Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Cell and Gene Therapy Bioanalytical Testing Services market size is poised to register ... Read More
-
Pharmaceutical Market Size, Trends, Analysis, and Outlook By Molecule (Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules), Pharmaceutical Product, Branded, Generic), By Type (Prescription, OTC, Pharmaceutical Disease, Cardiovascular diseases, Cancer, Diabetes, Infectious diseases, Neurological disorders, Respiratory, Autoimmune, Mental health disorders, Gastrointestinal disorders, Women’s health Diseases, Genetic and rare genetic diseases, Dermatological conditions, Obesity, Renal diseases, Liver conditions, Hematological disorders, Others), By Route of Administration (Oral, Topical, Parenteral, Other), By Formulation (Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Others), By Age group (Children & Adolescents, Adults, Geriatric), By End-user (Hospitals, Clinics, Others), by Region, Country, Segment, and Companies, 2024-2030
... disorders, Respiratory, Autoimmune, Mental health disorders, Gastrointestinal disorders, Women’s health Diseases, Genetic and rare genetic diseases, Dermatological conditions, Obesity, Renal diseases, Liver conditions, Hematological disorders, Others), By Route of Administration (Oral, Topical, Parenteral, Other), By ... Read More
-
Rare Diseases Treatment Market Size, Trends, Analysis, and Outlook By Therapeutic Area (Cancer, Neurological Conditions, Cardiovascular Conditions, Musculoskeletal Conditions, Hematologic Disorders, Infectious Diseases, Metabolic Diseases, Endocrine Disorders, Others), By Route of Administration (Oral, Injectable, Others), By Drug Type (Biologics, Biosimilar, Others), By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... By Drug Type (Biologics, Biosimilar, Others), By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030 The global Rare Diseases Treatment market size is poised to register 12.13% growth ... Read More
-
Recombinant Proteinrapeutics CDMO Market Size, Trends, Analysis, and Outlook By Type (Growth Hormones, Interferons, Vaccines, Immunostimulating Agents, Others), By Source (Mammalian Systems, Microbial Systems, Others), By Indication (Oncology, Infectious Diseases, Immunological Disorders, Metabolic Disorders, Haematological Disorders, Others), by Region, Country, Segment, and Companies, 2024-2030
... Disorders, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Recombinant Proteinrapeutics CDMO market size is poised to register 12.58% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the ... Read More
-
Point of Care Infectious Disease Testing Market Size, Trends, Analysis, and Outlook By Disease (HIV POC, Clostridium difficile POC, HBV POC, Pneumonia or Streptococcus associated infections, Respiratory syncytial virus (RSV) POC, HPV POC, Influenza/Flu POC, HCV POC, MRSA POC, TB and drug-resistant TB POC, HSV (Herpes Simplex Virus) POC, Others), By End-user (Hospitals, Clinics, Home, Assisted Living Healthcare Facilities, Laboratories, Others), by Region, Country, Segment, and Companies, 2024-2030
... HCV POC, MRSA POC, TB and drug-resistant TB POC, HSV (Herpes Simplex Virus) POC, Others), By End-user (Hospitals, Clinics, Home, Assisted Living Healthcare Facilities, Laboratories, Others), by Region, Country, Segment, and Companies, 2024-2030 The global ... Read More
-
Global Hospital Acquired Pneumonia Drugs Market Growth 2024-2030
... in downstream market, the Hospital Acquired Pneumonia Drugs is forecast to a readjusted size of US$ 3059.9 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential ... Read More
-
mRNA Therapeutics Market Size, Trends, Analysis, and Outlook By Product (Vaccines, Drugs), By Application (Infectious Diseases, Rare Genetic Diseases, Respiratory Diseases, Others), By End-user (Hospitals & Clinics, Research & Others), by Region, Country, Segment, and Companies, 2024-2030
... Companies, 2024-2030 The global mRNA Therapeutics market size is poised to register 2.16% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global mRNA ... Read More
-
mRNA Therapeutics Contract Development and Manufacturing Market Size, Trends, Analysis, and Outlook By Application (Viral Vaccines, Protein Replacement Therapies, Cancer Immunotherapies), By Indication (Infectious Diseases, Metabolic & Genetic Diseases, Cardiovascular & Cerebrovascular Diseases), By End-user (Biotech Companies, Pharmaceutical companies, Government & Academic Research Institutes), by Region, Country, Segment, and Companies, 2024-2030
... (Biotech Companies, Pharmaceutical companies, Government & Academic Research Institutes), by Region, Country, Segment, and Companies, 2024-2030 The global mRNA Therapeutics Contract Development and Manufacturing market size is poised to register 11.37% growth from 2024 to ... Read More
-
The 2025-2030 World Outlook for Hospital Infection Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Zika Virus Testing
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Zika Virus Vaccines
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Veterinary Infectious Disease Diagnostics
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Hospital-Acquired Pneumonia Prevention
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Antibacterial Hospital Acquired Pneumonia Drugs
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Infectious Disease Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Pneumonia Testing
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Flu Vaccines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Hospital Acquired Disease Testing
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
Research Assistance
